AN OPEN LABEL, TWO PERIODS, TWO SEQUENCES, CROSSOVER, RANDOMIZED MULTIPLE DOSE BIOEQUIVALENCE STUDY OF GUANFACINE 7 MG PROLONGED-RELEASE TABLETS (TEST FORMULATION) VS. EQUAL DOSE OF INTUNIV® PROLONGED-RELEASE TABLETS (REFERENCE FORMULATION) IN HEALTHY MALE VOLUNTEERS UNDER FASTING CONDITIONS
GFC-BEMD-01-NXP/23
Phase 1 other active
Quick answer
AN OPEN LABEL, TWO PERIODS, TWO SEQUENCES, CROSSOVER, RANDOMIZED MULTIPLE DOSE BIOEQUIVALENCE STUDY OF GUANFACINE 7 MG PROLONGED-RELEASE TABLETS (TEST FORMULATION) VS. EQUAL DOSE OF INTUNIV® PROLONGED-RELEASE TABLETS (REFERENCE FORMULATION) IN HEALTHY MALE VOLUNTEERS UNDER FASTING CONDITIONS for Study performed on healthy volunteers. is a Phase 1 program (other) at Neuraxpharm Pharmaceuticals S.L. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Neuraxpharm Pharmaceuticals S.L.
- Indication
- Study performed on healthy volunteers.
- Phase
- Phase 1
- Modality
- other
- Status
- active